Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 13/20 | 0.44 |
| ▸ | TLR8 | Q9NR97 | 7/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.35 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.35 |
| ▸ | PDE8B | O95263 | 4/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29697240 | 1.00 | TLR7 (0.44) | TLR7TLR8ADORA2AADORA2BPDE8B | |
| SCHEMBL2195829 | 1.00 | TLR7 (0.44) | TLR7TLR8ADORA2AADORA2BPDE8B | |
| SCHEMBL565796 | 1.00 | TLR7 (0.44) | TLR7TLR8ADORA2AADORA2BPDE8B | |
| SCHEMBL567026 | 0.94 | TLR7 (0.41) | TLR7TLR8ADORA2AADORA2BPDE8B | |
| SCHEMBL3265229 | 0.94 | TLR7 (0.41) | TLR7TLR8ADORA2AADORA2BPDE8B | |
| SCHEMBL566039 | 0.92 | ADORA2A (0.41) | TLR7TLR8ADORA2AADORA2BPDE8B | |
| SCHEMBL20701858 | 0.92 | ADORA2A (0.41) | TLR7TLR8ADORA2AADORA2BPDE8B | |
| SCHEMBL2199097 | 0.88 | TLR7 (0.37) | TLR7TLR8ADORA2AADORA2BPDE8B | |
| SCHEMBL13008597 | 0.88 | TLR7 (0.44) | TLR7TLR8ADORA2AADORA2BPDE8B | |
| SCHEMBL566720 | 0.88 | ADORA2A (0.37) | TLR7ADORA2AADORA2BPDE8BADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10919894-B2 | Adenine derivatives which are useful in the treatment of allergic diseases or other inflammatory conditions | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2021-02-16 | — | — | US | disclosed |
| US-20200223849-A1 | ADENINE DERIVATIVES WHICH ARE USEFUL IN THE TREATMENT OF ALLERGIC DISEASES OR OTHER INFLAMMATORY CONDITIONS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2020-07-16 | — | — | US | disclosed |
| US-10584125-B2 | Adenine derivatives which are useful in the treatment of allergic diseases or other inflammatory conditions | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2020-03-10 | — | — | US | disclosed |
| US-20180291026-A1 | ADENINE DERIVATIVES WHICH ARE USEFUL IN THE TREATMENT OF ALLERGIC DISEASES OR OTHER INFLAMMATORY CONDITIONS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2018-10-11 | — | — | US | disclosed |
| EP-2324026-B1 | PURINE DERIVATIVES FOR USE IN THE TREATMENT OF ALLERGIC, INFLAMMATORY AND INFECTIOUS DISEASES | GLAXOSMITHKLINE LLC (US) | 2015-07-08 | — | — | EP | disclosed |
| US-20120283438-A1 | COMPOUNDS | GLAXOSMITHKLINE LLC (US) | 2012-11-08 | — | — | US | disclosed |
| US-20120283438-A1 | COMPOUNDS | GLAXOSMITHKLINE LLC (US) | 2012-11-08 | — | — | US | disclosed |
| US-20120283438-A1 | COMPOUNDS | GLAXOSMITHKLINE LLC (US) | 2012-11-08 | — | — | US | disclosed |
| US-20110269781-A1 | COMPOUNDS | GLAXOSMITHKLINE LLC (US) | 2011-11-03 | — | — | US | disclosed |
| US-20110269781-A1 | COMPOUNDS | GLAXOSMITHKLINE LLC (US) | 2011-11-03 | — | — | US | disclosed |
| US-7977344-B2 | Compounds | GLAXOSMITHKLINE LLC (US) | 2011-07-12 | — | — | US | disclosed |
| US-7977344-B2 | Compounds | GLAXOSMITHKLINE LLC (US) | 2011-07-12 | — | — | US | disclosed |
| US-7977344-B2 | Compounds | GLAXOSMITHKLINE LLC (US) | 2011-07-12 | — | — | US | disclosed |
| EP-2125792-B1 | PURINE DERIVATIVES AS IMMUNOMODULATORS | GLAXOSMITHKLINE LLC (US) | 2010-12-01 | — | — | EP | disclosed |
| US-20100120799-A1 | PURINE DERIVATIVES AS IMMUNOMODULATORS | SMITHKLINE BEECHAM CORPORATION (US) | 2010-05-13 | — | — | US | disclosed |
| US-20100120799-A1 | PURINE DERIVATIVES AS IMMUNOMODULATORS | SMITHKLINE BEECHAM CORPORATION (US) | 2010-05-13 | — | — | US | disclosed |
| US-20100120799-A1 | PURINE DERIVATIVES AS IMMUNOMODULATORS | SMITHKLINE BEECHAM CORPORATION (US) | 2010-05-13 | — | — | US | disclosed |
| US-20090131458-A1 | Compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2009-05-21 | — | — | US | disclosed |
| US-20090131458-A1 | Compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2009-05-21 | — | — | US | disclosed |
| US-20090131458-A1 | Compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2009-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120283438-A1 | COMPOUNDS | LTC4S, LTB4R2, LTB4R | TLR7 38/4885TLR8 34/4885ADORA2A 907/4885 |
| US-20090131458-A1 | Compounds | LTC4S, LTB4R2, LTB4R | TLR7 38/4885TLR8 34/4885ADORA2A 907/4885 |
| US-20100120799-A1 | PURINE DERIVATIVES AS IMMUNOMODULATORS | LTC4S, STING1, LTB4R2 | TLR7 58/4885TLR8 152/4885ADORA2A 54/4885 |
| US-20180291026-A1 | ADENINE DERIVATIVES WHICH ARE USEFUL IN THE TREATMENT OF ALLERGIC DISEASES OR OTHER INFLAMMATORY CONDITIONS | HRH3, HRH4, HRH1 | TLR7 15/4885TLR8 91/4885ADORA2A 21/4885 |
| US-10584125-B2 | Adenine derivatives which are useful in the treatment of allergic diseases or other inflammatory conditions | HRH3, HRH4, HRH1 | TLR7 15/4885TLR8 91/4885ADORA2A 21/4885 |
| US-20200223849-A1 | ADENINE DERIVATIVES WHICH ARE USEFUL IN THE TREATMENT OF ALLERGIC DISEASES OR OTHER INFLAMMATORY CONDITIONS | HRH3, HRH4, HRH1 | TLR7 15/4885TLR8 89/4885ADORA2A 22/4885 |
| US-20110269781-A1 | COMPOUNDS | LTC4S, LTB4R2, LTB4R | TLR7 38/4885TLR8 34/4885ADORA2A 907/4885 |
| US-10919894-B2 | Adenine derivatives which are useful in the treatment of allergic diseases or other inflammatory conditions | HRH3, HRH4, HRH1 | TLR7 15/4885TLR8 91/4885ADORA2A 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.